Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000880984-22-000007)

Filing Details

Accession Number:: 0000880984-22-000007
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-06-07 20:11:10
Reporting Period:: 2022-06-03

Accepted Time:: 2022-06-07 20:11:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1719406	Nrx Pharmaceuticals Inc.	NRXP	Pharmaceutical Preparations (2834)	822844431

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1864534	C. Daniel Javitt	1201 North Market Street Suite 111 Wilmington DE 19801		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-06-03	243,596	$0.70	12,859,080	No	4	S	Indirect	by Glytech LLC
Common Stock	Disposition	2022-06-06	115,657	$0.67	12,743,423	No	4	S	Indirect	by Glytech LLC
Common Stock	Disposition	2022-06-07	86,459	$0.65	12,656,964	No	4	S	Indirect	by Glytech LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	by Glytech LLC
No	4	S	Indirect	by Glytech LLC
No	4	S	Indirect	by Glytech LLC

Footnotes

Held by Glytech LLC of which the Reporting Person is the sole owner.